Literature DB >> 35552208

Samantha S Moe1, Betsy Thomas2, Michael R Kolber3, Christina S Korownyk4, Adrienne J Lindblad5, Nicolas Dugré6, Ricky D Turgeon7, Emélie Braschi8, G Michael Allan9.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35552208      PMCID： PMC9097739          DOI： 10.46747/cfp.6805334

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.025


× No keyword cloud information.
  13 in total

1.  Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.

Authors:  Weili Zhang; Shuyuan Zhang; Yue Deng; Shouling Wu; Jie Ren; Gang Sun; Jinfeng Yang; Yinong Jiang; Xinjuan Xu; Tzung-Dau Wang; Youren Chen; Yufeng Li; Lianchen Yao; Dianfang Li; Lixin Wang; Xiaomei Shen; Xinhua Yin; Wei Liu; Xiaoyang Zhou; Bingpo Zhu; Zihong Guo; Hualing Liu; Xiaoping Chen; Yingqing Feng; Gang Tian; Xiuyin Gao; Kazuomi Kario; Jun Cai
Journal:  N Engl J Med       Date:  2021-08-30       Impact factor: 91.245

2.  Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.

Authors:  Clara K Chow; Emily R Atkins; Graham S Hillis; Mark R Nelson; Christopher M Reid; Markus P Schlaich; Peter Hay; Kris Rogers; Laurent Billot; Michael Burke; John Chalmers; Bruce Neal; Anushka Patel; Tim Usherwood; Ruth Webster; Anthony Rodgers
Journal:  Lancet       Date:  2021-08-29       Impact factor: 79.321

3.  Empagliflozin in Heart Failure with a Preserved Ejection Fraction.

Authors:  Stefan D Anker; Javed Butler; Gerasimos Filippatos; João P Ferreira; Edimar Bocchi; Michael Böhm; Hans-Peter Brunner-La Rocca; Dong-Ju Choi; Vijay Chopra; Eduardo Chuquiure-Valenzuela; Nadia Giannetti; Juan Esteban Gomez-Mesa; Stefan Janssens; James L Januzzi; Jose R Gonzalez-Juanatey; Bela Merkely; Stephen J Nicholls; Sergio V Perrone; Ileana L Piña; Piotr Ponikowski; Michele Senni; David Sim; Jindrich Spinar; Iain Squire; Stefano Taddei; Hiroyuki Tsutsui; Subodh Verma; Dragos Vinereanu; Jian Zhang; Peter Carson; Carolyn Su Ping Lam; Nikolaus Marx; Cordula Zeller; Naveed Sattar; Waheed Jamal; Sven Schnaidt; Janet M Schnee; Martina Brueckmann; Stuart J Pocock; Faiez Zannad; Milton Packer
Journal:  N Engl J Med       Date:  2021-08-27       Impact factor: 176.079

4.  Randomized controlled trial of skin-to-skin contact from birth versus conventional incubator for physiological stabilization in 1200- to 2199-gram newborns.

Authors:  N J Bergman; L L Linley; S R Fawcus
Journal:  Acta Paediatr       Date:  2004-06       Impact factor: 2.299

5.  Maintenance or Discontinuation of Antidepressants in Primary Care.

Authors:  Gemma Lewis; Louise Marston; Larisa Duffy; Nick Freemantle; Simon Gilbody; Rachael Hunter; Tony Kendrick; David Kessler; Dee Mangin; Michael King; Paul Lanham; Michael Moore; Irwin Nazareth; Nicola Wiles; Faye Bacon; Molly Bird; Sally Brabyn; Alison Burns; Caroline S Clarke; Anna Hunt; Jodi Pervin; Glyn Lewis
Journal:  N Engl J Med       Date:  2021-09-30       Impact factor: 91.245

6.  Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis.

Authors:  Masaki Kato; Hikaru Hori; Takeshi Inoue; Junichi Iga; Masaaki Iwata; Takahiko Inagaki; Kiyomi Shinohara; Hissei Imai; Atsunobu Murata; Kazuo Mishima; Aran Tajika
Journal:  Mol Psychiatry       Date:  2020-07-23       Impact factor: 15.992

7.  Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.

Authors:  Sanjay Ramakrishnan; Dan V Nicolau; Beverly Langford; Mahdi Mahdi; Helen Jeffers; Christine Mwasuku; Karolina Krassowska; Robin Fox; Ian Binnian; Victoria Glover; Stephen Bright; Christopher Butler; Jennifer L Cane; Andreas Halner; Philippa C Matthews; Louise E Donnelly; Jodie L Simpson; Jonathan R Baker; Nabil T Fadai; Stefan Peterson; Thomas Bengtsson; Peter J Barnes; Richard E K Russell; Mona Bafadhel
Journal:  Lancet Respir Med       Date:  2021-04-09       Impact factor: 30.700

8.  Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.

Authors:  Ly-Mee Yu; Mona Bafadhel; Jienchi Dorward; Gail Hayward; Benjamin R Saville; Oghenekome Gbinigie; Oliver Van Hecke; Emma Ogburn; Philip H Evans; Nicholas P B Thomas; Mahendra G Patel; Duncan Richards; Nicholas Berry; Michelle A Detry; Christina Saunders; Mark Fitzgerald; Victoria Harris; Milensu Shanyinde; Simon de Lusignan; Monique I Andersson; Peter J Barnes; Richard E K Russell; Dan V Nicolau; Sanjay Ramakrishnan; F D Richard Hobbs; Christopher C Butler
Journal:  Lancet       Date:  2021-08-10       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.